173 related articles for article (PubMed ID: 38589266)
1. Associations between intravaginal practices and incidence of sexually transmitted infections and bacterial vaginosis among women enrolled in the dapivirine vaginal ring trial (The Ring Study) in southwestern Uganda: a retrospective secondary analysis.
Kusemererwa S; Ruzagira E; Onyango M; Kabarambi A; Abaasa A
BMJ Open; 2024 Apr; 14(4):e079497. PubMed ID: 38589266
[TBL] [Abstract][Full Text] [Related]
2. Molecular Identification of Cervical Microbes in HIV-Negative and HIV-Positive Women in an African Setting Using a Customized Bacterial Vaginosis Microbial DNA Quantitative PCR (qPCR) Array.
Taku O; Onywera H; Mbulawa ZZA; Businge CB; Meiring TL; Williamson AL
Microbiol Spectr; 2022 Jun; 10(3):e0222921. PubMed ID: 35647888
[TBL] [Abstract][Full Text] [Related]
3. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia.
Shipitsyna E; Khusnutdinova T; Budilovskaya O; Krysanova A; Shalepo K; Savicheva A; Unemo M
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1221-1230. PubMed ID: 32036466
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women.
Kiweewa FM; Brown E; Mishra A; Nair G; Palanee-Phillips T; Mgodi N; Nakabiito C; Chakhtoura N; Hillier SL; Baeten JM;
J Int AIDS Soc; 2019 Feb; 22(2):e25257. PubMed ID: 30816632
[TBL] [Abstract][Full Text] [Related]
5. Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study.
Nel A; van Niekerk N; Van Baelen B; Malherbe M; Mans W; Carter A; Steytler J; van der Ryst E; Craig C; Louw C; Gwetu T; Mabude Z; Kotze P; Moraba R; Tempelman H; Gill K; Kusemererwa S; Bekker LG; Devlin B; Rosenberg Z;
Lancet HIV; 2021 Feb; 8(2):e77-e86. PubMed ID: 33539761
[TBL] [Abstract][Full Text] [Related]
6. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
Baeten JM; Palanee-Phillips T; Mgodi NM; Mayo AJ; Szydlo DW; Ramjee G; Gati Mirembe B; Mhlanga F; Hunidzarira P; Mansoor LE; Siva S; Govender V; Makanani B; Naidoo L; Singh N; Nair G; Chinula L; Parikh UM; Mellors JW; Balán IC; Ngure K; van der Straten A; Scheckter R; Garcia M; Peda M; Patterson K; Livant E; Bunge K; Singh D; Jacobson C; Jiao Y; Hendrix CW; Chirenje ZM; Nakabiito C; Taha TE; Jones J; Torjesen K; Nel A; Rosenberg Z; Soto-Torres LE; Hillier SL; Brown ER;
Lancet HIV; 2021 Feb; 8(2):e87-e95. PubMed ID: 33539762
[TBL] [Abstract][Full Text] [Related]
7. A bio-behavioral intervention to decrease intravaginal practices and bacterial vaginosis among HIV infected Zambian women, a randomized pilot study.
Alcaide ML; Chisembele M; Malupande E; Rodriguez VJ; Fischl MA; Arheart K; Jones DL
BMC Infect Dis; 2017 May; 17(1):338. PubMed ID: 28494795
[TBL] [Abstract][Full Text] [Related]
8. Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections.
Balkus JE; Manhart LE; Lee J; Anzala O; Kimani J; Schwebke J; Shafi J; Rivers C; Kabare E; Scott McClelland R
J Infect Dis; 2016 Jun; 213(12):1932-7. PubMed ID: 26908758
[TBL] [Abstract][Full Text] [Related]
9. Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV.
Barnabas SL; Dabee S; Passmore JS; Jaspan HB; Lewis DA; Jaumdally SZ; Gamieldien H; Masson L; Muller E; Maseko VD; Mkhize N; Mbulawa Z; Williamson AL; Gray CM; Hope TJ; Chiodi F; Dietrich J; Gray G; Bekker LG;
Int J STD AIDS; 2018 May; 29(6):531-539. PubMed ID: 29198180
[TBL] [Abstract][Full Text] [Related]
10. Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trial.
Balle C; Gill K; Konstantinus IN; Jaumdally SZ; Lennard K; Esra R; Happel AU; Barnabas SL; Gamieldien H; Pidwell T; Maseko V; Lesosky M; Myer L; Passmore JS; Bekker LG; Jaspan HB
Sex Transm Infect; 2021 Mar; 97(2):112-117. PubMed ID: 32989170
[TBL] [Abstract][Full Text] [Related]
11. Prevalent bacterial vaginosis infection - a risk factor for incident sexually transmitted infections in women in Durban, South Africa.
Abbai NS; Reddy T; Ramjee G
Int J STD AIDS; 2016 Dec; 27(14):1283-1288. PubMed ID: 26538552
[TBL] [Abstract][Full Text] [Related]
12. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study.
Masson L; Mlisana K; Little F; Werner L; Mkhize NN; Ronacher K; Gamieldien H; Williamson C; Mckinnon LR; Walzl G; Abdool Karim Q; Abdool Karim SS; Passmore JA
Sex Transm Infect; 2014 Dec; 90(8):580-7. PubMed ID: 25107710
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of sexually transmitted infections among women screened for a contraceptive intravaginal ring study, Kisumu, Kenya, 2014.
Oliver VO; Otieno G; Gvetadze R; Desai MA; Makanga M; Akelo V; Gust DA; Nyagol B; McLellan-Lemal E
Int J STD AIDS; 2018 Dec; 29(14):1390-1399. PubMed ID: 30071799
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis.
Sewankambo N; Gray RH; Wawer MJ; Paxton L; McNaim D; Wabwire-Mangen F; Serwadda D; Li C; Kiwanuka N; Hillier SL; Rabe L; Gaydos CA; Quinn TC; Konde-Lule J
Lancet; 1997 Aug; 350(9077):546-50. PubMed ID: 9284776
[TBL] [Abstract][Full Text] [Related]
15. Chlamydia trachomatis, Neisseria gonorrhoea, and Trichomonas vaginalis infections among pregnant women and male partners in Dutch midwifery practices: prevalence, risk factors, and perinatal outcomes.
Op de Coul ELM; Peek D; van Weert YWM; Morré SA; Rours I; Hukkelhoven C; de Jonge A; van Benthem B; Pereboom M
Reprod Health; 2021 Jun; 18(1):132. PubMed ID: 34174905
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of curable sexually transmitted infections among pregnant women in a rural county hospital in Kilifi, Kenya.
Masha SC; Wahome E; Vaneechoutte M; Cools P; Crucitti T; Sanders EJ
PLoS One; 2017; 12(3):e0175166. PubMed ID: 28362869
[TBL] [Abstract][Full Text] [Related]
17. Assessment of risk compensation following use of the dapivirine vaginal ring in southwestern Uganda.
Kusemererwa S; Abaasa A; Kabarambi A; Onyango M; Mugisha JO
Sex Transm Infect; 2022 Feb; 98(1):32-37. PubMed ID: 33542153
[TBL] [Abstract][Full Text] [Related]
18. A novel point-of-care testing strategy for sexually transmitted infections among pregnant women in high-burden settings: results of a feasibility study in Papua New Guinea.
Badman SG; Vallely LM; Toliman P; Kariwiga G; Lote B; Pomat W; Holmer C; Guy R; Luchters S; Morgan C; Garland SM; Tabrizi S; Whiley D; Rogerson SJ; Mola G; Wand H; Donovan B; Causer L; Kaldor J; Vallely A
BMC Infect Dis; 2016 Jun; 16():250. PubMed ID: 27268218
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
Torrone EA; Morrison CS; Chen PL; Kwok C; Francis SC; Hayes RJ; Looker KJ; McCormack S; McGrath N; van de Wijgert JHHM; Watson-Jones D; Low N; Gottlieb SL;
PLoS Med; 2018 Feb; 15(2):e1002511. PubMed ID: 29485986
[TBL] [Abstract][Full Text] [Related]
20. Analysis of bacterial vaginosis, the vaginal microbiome, and sexually transmitted infections following the provision of menstrual cups in Kenyan schools: Results of a nested study within a cluster randomized controlled trial.
Mehta SD; Zulaika G; Agingu W; Nyothach E; Bhaumik R; Green SJ; van Eijk AM; Kwaro D; Otieno F; Phillips-Howard P
PLoS Med; 2023 Jul; 20(7):e1004258. PubMed ID: 37490459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
